Zepbound permitted for sleep apnea
The Meals and Drug Administration on Friday permitted Eli Lilly’s weight-loss drug Zepbound as a remedy for moderate-to-severe sleep apnea and weight problems. Zepbound is the primary medicine permitted to deal with sufferers with obstructive sleep apnea, stated Sally Seymour, the FDA’s director of the division of pulmonology, allergy and demanding care. The FDA stated
Read More